These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25605418)
61. Image analysis and multi-layer perceptron artificial neural networks for the discrimination between benign and malignant endometrial lesions. Makris GM; Pouliakis A; Siristatidis C; Margari N; Terzakis E; Koureas N; Pergialiotis V; Papantoniou N; Karakitsos P Diagn Cytopathol; 2017 Mar; 45(3):202-211. PubMed ID: 28160459 [TBL] [Abstract][Full Text] [Related]
62. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases. Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983 [TBL] [Abstract][Full Text] [Related]
63. Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Mai KT; Ball CG; Kos Z; Belanger EC; Islam S; Sekhon H Diagn Cytopathol; 2014 Jul; 42(7):555-63. PubMed ID: 24273035 [TBL] [Abstract][Full Text] [Related]
64. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A; Kumar R; Gupta NP Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [TBL] [Abstract][Full Text] [Related]
65. Cytomorphological characteristics of low-grade papillary urothelial carcinoma for differential diagnosis from benign papillary urothelial lesions: logistic regression analysis in SurePath(™) liquid-based voided urine cytology. Chung YR; Won JK; Park IA; Moon KC; Chung SY; Lee K; Ryu HS Cytopathology; 2016 Apr; 27(2):83-90. PubMed ID: 25580773 [TBL] [Abstract][Full Text] [Related]
66. Current status of urine cytology: What new does The Paris System for Reporting Urine Cytology bring? Pivovarčíková K; Pitra T; Hes O Cesk Patol; 2019; 55(1):34-41. PubMed ID: 30939885 [TBL] [Abstract][Full Text] [Related]
67. Sensitivity of exfoliative cytology in bladder cancer using the divided one-urine specimen examination. Theodorou C; Goulandris N; Kotzia-Theodorou E; Nacopoulou L; Kyrkos KA; Dimopoulos C Br J Urol; 1984 Feb; 56(1):48-9. PubMed ID: 6199070 [TBL] [Abstract][Full Text] [Related]
68. Static cytometry and neural networks in the discrimination of lower urinary system lesions. Pantazopoulos D; Karakitsos P; Pouliakis A; Iokim-Liossi A; Dimopoulos MA Urology; 1998 Jun; 51(6):946-50. PubMed ID: 9609631 [TBL] [Abstract][Full Text] [Related]
70. Digital image classification with the help of artificial neural network by simple histogram. Dey P; Banerjee N; Kaur R J Cytol; 2016; 33(2):63-5. PubMed ID: 27279679 [TBL] [Abstract][Full Text] [Related]
71. Neural network-based segmentation and classification system for automated grading of histologic sections of bladder carcinoma. Spyridonos P; Cavouras D; Ravazoula P; Nikiforidis G Anal Quant Cytol Histol; 2002 Dec; 24(6):317-24. PubMed ID: 12508689 [TBL] [Abstract][Full Text] [Related]
72. Synchronous uterine and bladder cancers detected in urine and vaginal samples by cytology. Narine N; Rana D; Shelton D; Awad D; O'Flynn H; Jones ER; Ryan NAJ; Crosbie EJ Diagn Cytopathol; 2022 Mar; 50(3):E86-E91. PubMed ID: 34783454 [TBL] [Abstract][Full Text] [Related]
73. Using a deep learning neural network for the identification of malignant cells in effusion cytology material. Sanyal P; Dey P Cytopathology; 2023 Sep; 34(5):466-471. PubMed ID: 37350108 [TBL] [Abstract][Full Text] [Related]
74. Potential of the back propagation neural network in the discrimination of benign from malignant gastric cells. Karakitsos P; Stergiou EB; Pouliakis A; Tzivras M; Archimandritis A; Liossi AI; Kyrkou K Anal Quant Cytol Histol; 1996 Jun; 18(3):245-50. PubMed ID: 8790840 [TBL] [Abstract][Full Text] [Related]
75. Comparative study of artificial neural networks in the discrimination between benign from malignant gastric cells. Karakitsos P; Stergiou EB; Pouliakis A; Tzivras M; Archimandritis A; Liossi A; Kyrkou K Anal Quant Cytol Histol; 1997 Apr; 19(2):145-52. PubMed ID: 9113307 [TBL] [Abstract][Full Text] [Related]
76. Bladder cancer diagnosis by computer image analysis of cells in the sediment of voided urine using a video scanning system. Sherman AB; Koss LG; Wyschogrod D; Melder KH; Eppich EM; Bales CE Anal Quant Cytol Histol; 1986 Sep; 8(3):177-86. PubMed ID: 3778610 [TBL] [Abstract][Full Text] [Related]
77. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Barkan GA; Wojcik EM; Nayar R; Savic-Prince S; Quek ML; Kurtycz DF; Rosenthal DL Adv Anat Pathol; 2016 Jul; 23(4):193-201. PubMed ID: 27233050 [TBL] [Abstract][Full Text] [Related]
78. [Accuracy of artificial neural networks in radiological differential diagnosis of solitary bone lesions]. Strotzer M; Krös P; Held P; Feuerbach S Rofo; 1995 Sep; 163(3):245-9. PubMed ID: 7548872 [TBL] [Abstract][Full Text] [Related]
79. Detection of bladder cancers using a SAMBA 200 cell image processor. Brugal G; Quirion C; Vassilakos P Anal Quant Cytol Histol; 1986 Sep; 8(3):187-94. PubMed ID: 3778611 [TBL] [Abstract][Full Text] [Related]
80. A smart tele-cytology point-of-care platform for oral cancer screening. Sunny S; Baby A; James BL; Balaji D; N V A; Rana MH; Gurpur P; Skandarajah A; D'Ambrosio M; Ramanjinappa RD; Mohan SP; Raghavan N; Kandasarma U; N S; Raghavan S; Hedne N; Koch F; Fletcher DA; Selvam S; Kollegal M; N PB; Ladic L; Suresh A; Pandya HJ; Kuriakose MA PLoS One; 2019; 14(11):e0224885. PubMed ID: 31730638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]